GlassScriptPhysician profile
Sina Rajamand
NPI 1598105280
$2,761.95
in general payments reported to CMS, 2019-2025
22 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $186 · 2021: $146 · 2022: $627 · 2023: $473 · 2024: $285 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $709.58 | 2021-2025 | Catalyft Pl Expandable Interbody System, Metrx System, Pivox Oblique Lateral Spinal System |
| Si-Bone, INC. | $541.95 | 2019-2025 | |
| Medtronic USA, INC. | $412.31 | 2019-2020 | |
| Stryker Corporation | $288.38 | 2019-2023 | Capri Corpectomy Cage System, Prolift, Vesuvius |
| Cerapedics INC. | $93.38 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $90.67 | 2019-2022 | |
| Providence Medical Technology, INC. | $84.60 | 2023 | |
| 4web, INC. | $79.67 | 2019 | |
| Abbott Laboratories | $69.33 | 2021 | |
| Lundbeck LLC | $59.58 | 2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $37.77 | 2023 | |
| Zimvie INC. | $35.84 | 2022-2023 | |
| Amgen INC. | $34.30 | 2022 | |
| Zimmer Biomet Holdings, INC. | $32.15 | 2020 | |
| Spineart USA INC | $31.83 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $28.39 | 2024 | Exparel |
| Kuros Biosciences USA, INC | $25.34 | 2024 | Magnetos |
| Nevro Corp. | $25.08 | 2022 | |
| Organogenesis INC. | $24.98 | 2024 | |
| Nuvasive, INC. | $21.09 | 2021 | |
| Relievant Medsystems, INC. | $20.98 | 2023 | Intracept |
| Gt Medical Technologies, INC | $14.75 | 2023 | Gammatile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sina Rajamand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.